A detailed history of Seeyond transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Seeyond holds 33,045 shares of BMRN stock, worth $2.2 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
33,045
Previous 50,713 34.84%
Holding current value
$2.2 Million
Previous $4.3 Million 20.45%
% of portfolio
0.33%
Previous 0.52%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$80.93 - $108.63 $1.43 Million - $1.92 Million
-17,668 Reduced 34.84%
33,045 $3.42 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $163,169 - $192,522
1,986 Added 4.08%
50,713 $4.3 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $1.79 Million - $2.17 Million
24,990 Added 105.28%
48,727 $4.04 Million
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $404,306 - $504,511
-5,443 Reduced 18.65%
23,737 $1.83 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $1.39 Million - $1.77 Million
19,356 Added 197.03%
29,180 $2.58 Million
Q3 2021

Nov 12, 2021

SELL
$74.77 - $85.47 $7,477 - $8,547
-100 Reduced 1.01%
9,824 $759,000
Q2 2021

Aug 13, 2021

BUY
$75.51 - $84.79 $3,397 - $3,815
45 Added 0.46%
9,924 $828,000
Q1 2021

May 14, 2021

SELL
$74.73 - $90.69 $277,771 - $337,094
-3,717 Reduced 27.34%
9,879 $745,000
Q4 2020

Feb 12, 2021

SELL
$72.61 - $90.2 $5,590 - $6,945
-77 Reduced 0.56%
13,596 $1.19 Million
Q3 2020

Nov 12, 2020

BUY
$71.87 - $131.03 $19,404 - $35,378
270 Added 2.01%
13,673 $1.04 Million
Q2 2020

Aug 13, 2020

BUY
$79.55 - $124.22 $319,075 - $498,246
4,011 Added 42.71%
13,403 $1.65 Million
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $5,138 - $6,973
-72 Reduced 0.76%
9,392 $84,000
Q3 2019

Nov 13, 2019

BUY
$67.4 - $85.11 $261,849 - $330,652
3,885 Added 69.64%
9,464 $638,000
Q2 2019

Aug 13, 2019

SELL
$80.35 - $93.9 $98,107 - $114,651
-1,221 Reduced 17.96%
5,579 $478,000
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $544,952 - $721,276
6,800 New
6,800 $579,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Seeyond Portfolio

Follow Seeyond and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.